Dr. Lymperopoulos earned a M.Sc. in Medicinal Chemistry followed by Ph.D. in Pharmacology, after graduating from the School of Pharmacy of the University of Patras, Greece. In 2004 he joined the lab of Dr. Walter Koch at Thomas Jefferson University, a former postdoctoral fellow of Nobel laureate Professor Robert Lefkowitz's. After a successful 5-year-long postdoctoral tenure in Wally's lab, he moved on to an independent faculty position at Nova Southeastern University in 2009. Since then, he has had several successes, awards and honors, most prominent among which elections as Fellow of the American Heart Association (FAHA) with its Council on Basic Cardiovascular Sciences (BCVS) and as Fellow of the European Society of Cardiology (FESC), as well as a 5-year Scientist Development Grant award from the American Heart Association (AHA). Dr. Lymperopoulos has also been a finalist for the AHA-sponsored Melvin L. Marcus Young Investigator Award in Basic Cardiovascular Sciences, and for the Cardiovascular Research Award of the Council on Basic Cardiovascular Sciences of the European Society of Cardiology (ESC). He currently holds one patent, with two more pending. Dr. Lymperopoulos serves as associate editor of five peer-reviewed journals, has edited one textbook and authored numerous book chapters. He also serves as a regular grant reviewer for the American Heart Association and for the American Association of Colleges of Pharmacy (AACP). Additionally, he is a regular peer-reviewer for several prestigious scientific journals, and has a very prolific publication record, including a lead author publication in “Nature Medicine” among his over 80 peer-reviewed, PubMed-indexed publications so far. His current h-index is 29 (>4,000 total citations in Google Scholar, as of March 2021).